How the TNM classification is defined and updated.
The UICC TNM Project has updated and expanded the TNM Classification since its inception. For more than 50 years, the TNM project has benefited from an active participation of internationally renowned experts in cancer staging, who reside on the TNM Core Committee and its sub-committees, the Evaluation Committee and the Prognostic Factors Committee.
The TNM Core Committee, co-chaired by Drs Mary Gospodarowicz and James Brierley, reflects the multidisciplinary, geographical representation and objectives of the TNM project, with precise responsibilities for each of its members.
The TNM Core Committee also includes representatives, from FIGO (International Federation of Gynecology and Obstetrics), IASLC (International Association for the Study of Lung Cancer) and the AJCC (American Joint Committee on Cancer), to maintain a unified TNM classification.
The TNM Core Group is responsible for project planning, analysis of information, decision-making and product generation. It is supported by the Evaluation Committee and Prognostic Factors Committee.
The Evaluation Committee oversees the compilation of new evidence and expert opinion relating to possible modifications of TNM and coordinates various activities.
The Prognostic Factors Core Group develops strategies relating to prognostic factors classification(s) relevant to clinical practice and is responsible for product development, including communication and timely reporting.
The TNM Global Advisory Group is a network of multidisciplinary national and regional TNM committees that promotes, disseminates and educates in the use of the classification. TNM National/Regional Committees contribute to the annual literature review by providing national publications and non-English language articles for consideration, along with evidence-based expert opinions on the development and enhancement of staging and prognostic factors classifcation. Committees are also encouraged to establish local language help desk functions to augment the global service provided via the UICC website.
The current Global Advisory Group is composed of representatives from all WHO regions.
TNM National and Regional Committees are active in 20 countries/regions: Australasia, Belgium, Brazil, Canada, China-Hong Kong-Macau, German-speaking countries, Gulf States, India, Israel, Italy, Japan, Netherlands, Poland, Russia, Singapore, SLACOM (South America), South Africa, Spain, Turkey, UK, USA (AJCC).
Please contact us if you wish to create a TNM Committee in your country or region: email@example.com
If you want to submit a proposal for change in the UICC TNM Classification, please consult the document How to submit proposals for change and contact us at firstname.lastname@example.org
For any other questions, please contact us at the following address: email@example.com
Published by the Union for International Cancer Control, the TNM Classification of Malignant Tumours (TNM) is a globally recognised standard for classifying the extent of spread of cancer.
TNM publications include The TNM Classification of Malignant Tumours 8th edition, The TNM Supplement, 5th Edition, the TNM Atlas and many others.
eCancer and UICC jointly produced a set of 7 modules on TNM staging for the purpose of educating and informing the global cancer community on the globally accepted classification of malignant tumours.
“Essential TNM” that can be used to collect stage data when complete information is not available.
Share this page